UMS AG: Noticeable Improvement in Q3 2011
Earnings per share (EPS) for the third quarter of the current year came to EUR 0.13, for an improvement of EUR 0.03 on the previous quarter. The Company reported EPS of EUR 0.16 in the third quarter of 2010. Adjusted for exchange rate differences, earnings in the prior-year period were EUR 0.15 per share.
"After a difficult second quarter, we succeeded in meeting our revenue and earnings targets in the third quarter. We made excellent progress in the integration of our acquired competitor Mobile Biopsy. We are close to operating at full capacity in our mobile radiology services business," explains Jorgen Madsen, Chairman of the Management Board of UMS AG. Work is being done on a host of other strategic initiatives to strengthen the UMS Group in 2012.
These include the development of new medical applications for the company's mobile service offering and expansion into other regional markets in South America.
For the full year 2011, the company is confirming its revised earnings target of between EUR 0.45 and EUR 0.55 per share. UMS AG intends to maintain its dividend policy for fiscal year 2011, provided that the USD/EUR exchange rate does not substantially deteriorate from its current level.
The complete report for the third quarter of 2011 is available as a PDF file in German and English on the company's website at www.umsag.com.
UMS United Medical Systems International AG
UMS International AG is a provider of innovative healthcare delivery concepts in the growth segment of high-tech medicine. UMS pioneered the mobile deployment of highclass medical systems and markets a comprehensive range of full-service solutions for hospitals and specialists. The forward-looking concepts include complete services for the customer, covering everything from system management to the provision of trained application specialists. The UMS Group currently has over 200 employees worldwide and serves over 600 customers.